Small Caps Dashboard
 

VOLPARA


Sector: Services

Industry: Cancer screening software

This company has game changing proprietary technology utilising AI to transform the early detection of breast cancer in the giant US market. It’s early stage and there a big risks, but it’s worth, at the very least, having a look at.

Volpara’s software enables early detection of breast cancer by utilising its proprietary artificial intelligence (AI) technology to improve breast screening. The technology allows for the objective measurement of breast density, which is associated with breast cancer risk.

Sales are climbing in the huge US market, aided by the acquisition of US based specialist radiology clinic management software provider, MRS Systems in June 2019 for US$14.6m. This has increased the company’s access to number of US breast imaging clinics by five times.

The New Zealand based med tech is early on in its lifecycle, but is showing strong growth. In FY19 (12 months to 31 March 2019) the company generated NZ$5m in revenues and almost doubled its gross profit to NZ$4.1m.

The bottom line loss increased from NZ$8.8m to NZ$11.7m. FY20 has started well with its annual recurring revenues (ARR - the normalised amount of cash the company expects to book over the next 12 months based on current contracts) was $NZ14.6m at the end of 1Q20 (30 June) and the company says it is on track to meet FY20 sales guidance of NZ$17.1m.

**FY21 Forecast 

UTRR Directors own stock in VHT.

See our recomndations.
Unlock

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porttitor semper molestie. Ut eleifend, erat eu pulvinar iaculis, odio nunc venenatis tellus, ut placerat lorem purus sed tellus. Duis ut leo vitae massa facilisis dictum sed a dui. Proin quis pulvinar purus, vestibulum lobortis justo.

 
  • Radar Rating Unlock
  • Market Cap ($m)* 248.8
  • Dividend Yield (%)* 0
  • NET CASH ($M) 24.2
  • * Data as of 18 January 2022

Latest Research Summary

VOLPARA HEALTH TECHNOLOGIES: RESEARCH TIP UPDATE - NOVEMBER 2021
25 Nov, 2021

Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas ut ex et est semper fringilla. Nam et lectus augue. Integer non consectetur ligula. Maecenas tortor metus, molestie at aliquam sit amet, feugiat sed ipsum. Donec vehicula mi ac neque tempor dignissim.

Unlock to view the latest research

Previous Research

Research Date Radar Rating  
VOLPARA HEALTH TECHNOLOGIES: RESEARCH TIP UPDATE - NOVEMBER 2021 25 Nov, 2021 7db7f8dc View Research
VOLPARA HEALTH TECHNOLOGIES: RESEARCH TIP UPDATE - OCTOBER 2021 14 Oct, 2021 175c71a6 View Research
VOLPARA HEALTH TECHNOLOGIES: RESEARCH TIP UPDATE - SEPTEMBER 2021 16 Sep, 2021 7ec31a7d View Research
VOLPARA HEALTH: RESEARCH TIP UPDATE - JUNE 2021 03 Jun, 2021 3651d9c9 View Research
VOLPARA HEALTH TECH: RESEARCH TIP UPDATES - April 2021 29 Apr, 2021 32d2112b View Research
VOLPARA HEALTH TECH : RESEARCH TIP UPDATES - FEBRUARY 2021 04 Feb, 2021 8ce5e497 View Research
VOLPARA HEALTH : RESEARCH TIP UPDATES - JANUARY 2021 21 Jan, 2021 8ce5fa0d View Research
VOLPARA HEALTH TECHNOLOGY : RESEARCH TIP UPDATES - DECEMBER 2020 03 Dec, 2020 f7acd89b View Research
VOLPARA HEALTH TECHNOLOGY: RESEARCH TIP UPDATES - OCTOBER 2020 22 Oct, 2020 7a74b443 View Research
VOLPARA: RESEARCH TIP UPDATES - OCTOBER 2020 15 Oct, 2020 fb42b941 View Research
VOLPARA HEALTH: RESEARCH TIP UPDATE - JULY 2020 09 Jul, 2020 9e0e4415 View Research
VOLPARA HEALTH: RESEARCH TIP UPDATE - JUNE 2020 04 Jun, 2020 3b99eab4 View Research
VOLPARA HEALTH: RESEARCH TIP UPDATE - APRIL 2020 30 Apr, 2020 996d1d3b View Research
VOLPARA HEALTH TECHNOLOGY: RESEARCH TIP UPDATE - NOVEMBER 2019 28 Nov, 2019 9acecce5 View Research
VOLPARA: RESEARCH TIP UPDATE - OCTOBER 2019 03 Oct, 2019 896882a3 View Research